Versandkostenfrei innerhalb Deutschlands
51,99 €
inkl. MwSt.
Versandkostenfrei*
Erscheint vorauss. 14. April 2026
Melden Sie sich
hier
hier
für den Produktalarm an, um über die Verfügbarkeit des Produkts informiert zu werden.
26 °P sammeln
- Broschiertes Buch
Andere Kunden interessierten sich auch für
Rebecca Tucker2026 Lippincott Pocket Drug Guide for Nurses24,99 €
Sue JordanThe Prescription Drug Guide for Nurses24,99 €
Jacqueline RhoadsAdvanced Health Assessment and Diagnostic Reasoning120,99 €
Lippincott Williams & WilkinsPharmacology Made Incredibly Easy54,99 €
Mari J WirfsThe Aprn and Pa's Complete Guide to Prescribing Drug Therapy 202457,99 €
Charles D CicconeDavis's Drug Guide for Rehabilitation Professionals81,99 €
Sandra Luz Martinez De CastilloCalculating Drug Dosages93,99 €-
-
-
Produktdetails
- Verlag: F.A. Davis Company
- 20th Edition
- Seitenzahl: 1496
- Erscheinungstermin: 14. April 2026
- Englisch
- ISBN-13: 9781719653879
- ISBN-10: 1719653879
- Artikelnr.: 76161520
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Department Chair and Associate Professor Thomas Jefferson University Jefferson School of Pharmacy Philadelphia, Pennsylvania
HOW TO USE DAVIS’S DRUG GUIDE FOR NURSES
EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS
PHARMACOGENOMICS
MEDICATION ERRORS: Improving Practices and Patient Safety
DETECTING AND MANAGING ADVERSE DRUG REACTIONS
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)
SPECIAL DOSING CONSIDERATIONS
The Pediatric Patient
The Older Adult Patient
Females of Reproductive Potential
Renal Impairment
Hepatic Impairment
Heart Failure
Body Size
Drug Interactions
THE CYTOCHROME P450 SYSTEM: What Is It and Why Should I Care?
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE
CLASSIFICATIONS
Anti-Alzheimer’s agents
Antianemics
Antianginals
Antianxiety agents
Antiarrhythmics
Antiasthmatics
Anticholinergics
Anticoagulants
Anticonvulsants
Antidepressants
Antidiabetics
Antidiarrheals
Antiemetics
Antifungals
Antihistamines
Antihypertensives
Anti-infectives
Antineoplastics
Antiparkinson agents
Antiplatelet agents
Antipsychotics
Antiretrovirals
Antirheumatics
Antituberculars
Antiulcer agents
Antivirals
Bone resorption inhibitors
Bronchodilators
Central nervous system stimulants
Corticosteroids
Hormones
Immunosuppressants
Laxatives
Lipid-lowering agents
Opioid analgesics
Sedative/hypnotics
Skeletal muscle relaxants
Thrombolytics
Vascular headache suppressants
Weight control agents
DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME
DRUGS APPROVED IN CANADA
NATURAL/HERBAL PRODUCTS
MEDICATION SAFETY TOOLS
APPENDICES
Appendix A. Recent Drug Approvals
Appendix B. Ophthalmic Medications
Appendix C. Medication Administration Techniques
Appendix D. Administering Medications to Children
Appendix E. Formulas Helpful for Calculating Doses
Appendix F. Pediatric Dosage Calculations
Appendix G. Normal Values of Common Laboratory Tests
Appendix H. Controlled Substance Schedules
Appendix I. Equianalgesic Dosing Guidelines
Appendix J. Food Sources for Specific Nutrients
Appendix K. Insulins and Insulin Therapy
Appendix L. Differences in U.S. and Candaian Pharmaceutical Practices
Appendix M. Routine Pediatric and Adult Immunizations
Appendix N. Combination Drugs (fadavis.com)
BIBLIOGRAPHY
COMPREHENSIVE GENERIC/TRADE/CLASSIFICATIONS INDEX
EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS
PHARMACOGENOMICS
MEDICATION ERRORS: Improving Practices and Patient Safety
DETECTING AND MANAGING ADVERSE DRUG REACTIONS
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)
SPECIAL DOSING CONSIDERATIONS
The Pediatric Patient
The Older Adult Patient
Females of Reproductive Potential
Renal Impairment
Hepatic Impairment
Heart Failure
Body Size
Drug Interactions
THE CYTOCHROME P450 SYSTEM: What Is It and Why Should I Care?
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE
CLASSIFICATIONS
Anti-Alzheimer’s agents
Antianemics
Antianginals
Antianxiety agents
Antiarrhythmics
Antiasthmatics
Anticholinergics
Anticoagulants
Anticonvulsants
Antidepressants
Antidiabetics
Antidiarrheals
Antiemetics
Antifungals
Antihistamines
Antihypertensives
Anti-infectives
Antineoplastics
Antiparkinson agents
Antiplatelet agents
Antipsychotics
Antiretrovirals
Antirheumatics
Antituberculars
Antiulcer agents
Antivirals
Bone resorption inhibitors
Bronchodilators
Central nervous system stimulants
Corticosteroids
Hormones
Immunosuppressants
Laxatives
Lipid-lowering agents
Opioid analgesics
Sedative/hypnotics
Skeletal muscle relaxants
Thrombolytics
Vascular headache suppressants
Weight control agents
DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME
DRUGS APPROVED IN CANADA
NATURAL/HERBAL PRODUCTS
MEDICATION SAFETY TOOLS
APPENDICES
Appendix A. Recent Drug Approvals
Appendix B. Ophthalmic Medications
Appendix C. Medication Administration Techniques
Appendix D. Administering Medications to Children
Appendix E. Formulas Helpful for Calculating Doses
Appendix F. Pediatric Dosage Calculations
Appendix G. Normal Values of Common Laboratory Tests
Appendix H. Controlled Substance Schedules
Appendix I. Equianalgesic Dosing Guidelines
Appendix J. Food Sources for Specific Nutrients
Appendix K. Insulins and Insulin Therapy
Appendix L. Differences in U.S. and Candaian Pharmaceutical Practices
Appendix M. Routine Pediatric and Adult Immunizations
Appendix N. Combination Drugs (fadavis.com)
BIBLIOGRAPHY
COMPREHENSIVE GENERIC/TRADE/CLASSIFICATIONS INDEX
HOW TO USE DAVIS’S DRUG GUIDE FOR NURSES
EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS
PHARMACOGENOMICS
MEDICATION ERRORS: Improving Practices and Patient Safety
DETECTING AND MANAGING ADVERSE DRUG REACTIONS
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)
SPECIAL DOSING CONSIDERATIONS
The Pediatric Patient
The Older Adult Patient
Females of Reproductive Potential
Renal Impairment
Hepatic Impairment
Heart Failure
Body Size
Drug Interactions
THE CYTOCHROME P450 SYSTEM: What Is It and Why Should I Care?
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE
CLASSIFICATIONS
Anti-Alzheimer’s agents
Antianemics
Antianginals
Antianxiety agents
Antiarrhythmics
Antiasthmatics
Anticholinergics
Anticoagulants
Anticonvulsants
Antidepressants
Antidiabetics
Antidiarrheals
Antiemetics
Antifungals
Antihistamines
Antihypertensives
Anti-infectives
Antineoplastics
Antiparkinson agents
Antiplatelet agents
Antipsychotics
Antiretrovirals
Antirheumatics
Antituberculars
Antiulcer agents
Antivirals
Bone resorption inhibitors
Bronchodilators
Central nervous system stimulants
Corticosteroids
Hormones
Immunosuppressants
Laxatives
Lipid-lowering agents
Opioid analgesics
Sedative/hypnotics
Skeletal muscle relaxants
Thrombolytics
Vascular headache suppressants
Weight control agents
DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME
DRUGS APPROVED IN CANADA
NATURAL/HERBAL PRODUCTS
MEDICATION SAFETY TOOLS
APPENDICES
Appendix A. Recent Drug Approvals
Appendix B. Ophthalmic Medications
Appendix C. Medication Administration Techniques
Appendix D. Administering Medications to Children
Appendix E. Formulas Helpful for Calculating Doses
Appendix F. Pediatric Dosage Calculations
Appendix G. Normal Values of Common Laboratory Tests
Appendix H. Controlled Substance Schedules
Appendix I. Equianalgesic Dosing Guidelines
Appendix J. Food Sources for Specific Nutrients
Appendix K. Insulins and Insulin Therapy
Appendix L. Differences in U.S. and Candaian Pharmaceutical Practices
Appendix M. Routine Pediatric and Adult Immunizations
Appendix N. Combination Drugs (fadavis.com)
BIBLIOGRAPHY
COMPREHENSIVE GENERIC/TRADE/CLASSIFICATIONS INDEX
EVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS
PHARMACOGENOMICS
MEDICATION ERRORS: Improving Practices and Patient Safety
DETECTING AND MANAGING ADVERSE DRUG REACTIONS
OVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)
SPECIAL DOSING CONSIDERATIONS
The Pediatric Patient
The Older Adult Patient
Females of Reproductive Potential
Renal Impairment
Hepatic Impairment
Heart Failure
Body Size
Drug Interactions
THE CYTOCHROME P450 SYSTEM: What Is It and Why Should I Care?
EDUCATING PATIENTS ABOUT SAFE MEDICATION USE
CLASSIFICATIONS
Anti-Alzheimer’s agents
Antianemics
Antianginals
Antianxiety agents
Antiarrhythmics
Antiasthmatics
Anticholinergics
Anticoagulants
Anticonvulsants
Antidepressants
Antidiabetics
Antidiarrheals
Antiemetics
Antifungals
Antihistamines
Antihypertensives
Anti-infectives
Antineoplastics
Antiparkinson agents
Antiplatelet agents
Antipsychotics
Antiretrovirals
Antirheumatics
Antituberculars
Antiulcer agents
Antivirals
Bone resorption inhibitors
Bronchodilators
Central nervous system stimulants
Corticosteroids
Hormones
Immunosuppressants
Laxatives
Lipid-lowering agents
Opioid analgesics
Sedative/hypnotics
Skeletal muscle relaxants
Thrombolytics
Vascular headache suppressants
Weight control agents
DRUG MONOGRAPHS IN ALPHABETICAL ORDER BY GENERIC NAME
DRUGS APPROVED IN CANADA
NATURAL/HERBAL PRODUCTS
MEDICATION SAFETY TOOLS
APPENDICES
Appendix A. Recent Drug Approvals
Appendix B. Ophthalmic Medications
Appendix C. Medication Administration Techniques
Appendix D. Administering Medications to Children
Appendix E. Formulas Helpful for Calculating Doses
Appendix F. Pediatric Dosage Calculations
Appendix G. Normal Values of Common Laboratory Tests
Appendix H. Controlled Substance Schedules
Appendix I. Equianalgesic Dosing Guidelines
Appendix J. Food Sources for Specific Nutrients
Appendix K. Insulins and Insulin Therapy
Appendix L. Differences in U.S. and Candaian Pharmaceutical Practices
Appendix M. Routine Pediatric and Adult Immunizations
Appendix N. Combination Drugs (fadavis.com)
BIBLIOGRAPHY
COMPREHENSIVE GENERIC/TRADE/CLASSIFICATIONS INDEX







